Fortis Healthcare Q4 Profit Jumps 42% YoY, Margins Expand

📰 Key Highlights Net Profit: ₹2.7B vs ₹1.9B YoY → +42% growth Revenue: ₹23.6B vs ₹20B YoY → +18% growth EBITDA: ₹5.3B vs ₹4.4B YoY → +20% growth EBITDA Margin: 22.51% vs 21.93% YoY → margin expansion of ~58 bps 📊 Fundamentals & Ratios PE Ratio (TTM): ~28x (vs healthcare sector average ~30x). ROE: ~13% (improved from ~10% last year). Debt-to-Equity: ~0.5 (moderate leverage). Dividend Yield: ~0.8% (steady payouts). 🏥 Business Focus & Projects Expanding hospital network in Delhi NCR, Bengaluru, and Mumbai. Strengthening diagnostics and pathology services. Focus on digital health, telemedicine, and AI-driven patient care. Strategic partnerships for oncology, cardiology, and critical care. ⚠️ Risks Regulatory changes in healthcare pricing and insurance coverage. High operating costs in hospital expansion. Dependence on urban demand and premium healthcare services. Competition from peers like Apollo Hospitals, Max Healthcare, and Narayana Hrudayalaya. 📈 Outlook Strong demand for healthcare services expected to continue. Margin expansion trend encouraging for sustained profitability. Fortis positioning itself as a leading integrated healthcare provider with focus on quality and scale.